|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 40.63 USD | +3.97% |
|
+10.53% | +22.16% |
| 09-10 | Brooks Automation confidentially files for US IPO | RE |
| 09-04 | Azenta Receives Early Repayment of $35 Million Vendor Loan | MT |
Business description: Azenta, Inc.
Number of employees: 2,900
Sales by Activity: Azenta, Inc.
| Fiscal Period: September | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Sample Management Solutions | - | - | - | 319M | 325M |
Multiomics | - | - | - | 255M | 269M |
Life Sciences Services | 314M | 356M | 360M | - | - |
Life Sciences Products | 200M | 199M | 305M | - | - |
B Medical Systems | - | - | - | 83.12M | - |
Geographical breakdown of sales: Azenta, Inc.
| Fiscal Period: September | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 321M | 371M | - | 366M | 365M |
Rest of Europe | - | - | 110M | 103M | 107M |
China | - | 48.09M | 51.79M | 58.26M | 58.35M |
United Kingdom | - | - | 26.76M | 27.45M | 35.39M |
Asia/Pacific | - | - | - | - | 23.28M |
Other | - | - | - | - | 4.43M |
Africa | - | - | 65.09M | 61.96M | - |
North America (Excl. US) | 3.18M | 3.01M | 359M | - | - |
Asia Pacific/Other | 80.92M | 28.97M | 52.16M | 39.67M | - |
Europe | 109M | 105M | - | - | - |
Executive Committee: Azenta, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Madaus
CEO | Chief Executive Officer | 66 | 2026-08-21 |
Lawrence Lin
DFI | Director of Finance/CFO | 49 | 2024-11-30 |
Michael Paulo
CTO | Chief Tech/Sci/R&D Officer | - | 2017-06-30 |
Yvonne Perron
IRC | Investor Relations Contact | - | 2024-02-29 |
Luc Provost
PRN | Corporate Officer/Principal | - | 2022-09-30 |
Composition of the Board of Directors: Azenta, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Robyn Davis
BRD | Director/Board Member | 64 | 2013-06-27 |
Erica McLaughlin
BRD | Director/Board Member | 50 | 2020-04-02 |
Frank Casal
CHM | Chairman | 72 | 2024-01-29 |
Tina Nova
BRD | Director/Board Member | 73 | 2023-01-30 |
Martin Madaus
BRD | Director/Board Member | 66 | 2024-01-29 |
William Cornog
BRD | Director/Board Member | 61 | 2024-10-31 |
Quentin Koffey
BRD | Director/Board Member | 48 | 2024-10-31 |
Dipal Doshi
BRD | Director/Board Member | 50 | 2025-01-29 |
Company details: Azenta, Inc.
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.97% | +10.53% | +29.54% | -12.38% | 1.71B | |
| +0.65% | -3.36% | +36.98% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +81.21% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +100.19% | 53.59B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 44.75B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 41.62B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 39.91B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +92.73% | 26.7B | |
| -2.68% | -1.06% | +22.42% | -11.33% | 23.36B | |
| Average | +3.79% | +1.10% | +49.97% | +144.47% | 38.21B | |
| Weighted average by Cap. | +2.81% | +0.24% | +47.88% | +160.18% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZTA Stock
- Company Azenta, Inc.
Select your edition
All financial news and data tailored to specific country editions
